These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25726032)

  • 1. Association of visit-to-visit variability of hemoglobin A1c and medication adherence.
    Ramachandran A; Winter M; Mann DM
    J Manag Care Spec Pharm; 2015 Mar; 21(3):229-37. PubMed ID: 25726032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol.
    Mann DM; Glazer NL; Winter M; Paasche-Orlow MK; Muntner P; Shimbo D; Adams WG; Kressin NR; Zhang Y; Choi H; Cabral H
    Am J Cardiol; 2013 May; 111(10):1437-42. PubMed ID: 23433758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes.
    Yeh ST; Ooi SW; Chang YH; Li CY; Chen HF
    Medicine (Baltimore); 2022 Aug; 101(33):e29942. PubMed ID: 35984136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes.
    O'Connor PJ; Schmittdiel JA; Pathak RD; Harris RI; Newton KM; Ohnsorg KA; Heisler M; Sterrett AT; Xu S; Dyer WT; Raebel MA; Thomas A; Schroeder EB; Desai JR; Steiner JF
    Diabetes Care; 2014 Dec; 37(12):3317-24. PubMed ID: 25315207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
    Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.
    Lawrence DB; Ragucci KR; Long LB; Parris BS; Helfer LA
    J Manag Care Pharm; 2006; 12(6):466-71. PubMed ID: 16925454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction.
    Kogut SJ; Johnson S; Higgins T; Quilliam B
    J Manag Care Pharm; 2012 May; 18(4):297-310. PubMed ID: 22548690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal effects of medication nonadherence on glycemic control.
    Egede LE; Gebregziabher M; Echols C; Lynch CP
    Ann Pharmacother; 2014 May; 48(5):562-70. PubMed ID: 24586059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin Levels.
    Zongo A; Guénette L; Moisan J; Grégoire JP
    Can J Diabetes; 2016 Feb; 40(1):58-65. PubMed ID: 26507401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.
    Saundankar V; Peng X; Fu H; Ascher-Svanum H; Rodriguez A; Ali A; Slabaugh L; Young P; Louder A
    J Manag Care Spec Pharm; 2016 May; 22(5):467-82. PubMed ID: 27123910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers.
    Surbhi S; Graetz I; Wan JY; Gatwood J; Bailey JE
    J Manag Care Spec Pharm; 2018 Mar; 24(3):198-207. PubMed ID: 29485952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of health literacy level on aspects of medication nonadherence reported by underserved patients with type 2 diabetes.
    Thurston MM; Bourg CA; Phillips BB; Huston SA
    Diabetes Technol Ther; 2015 Mar; 17(3):187-93. PubMed ID: 25531555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
    Ho PM; Rumsfeld JS; Masoudi FA; McClure DL; Plomondon ME; Steiner JF; Magid DJ
    Arch Intern Med; 2006 Sep; 166(17):1836-41. PubMed ID: 17000939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
    Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
    J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.